IL6 and atrial fibrillation: By focusing on IL-6 and deriving data from studies that measured it in several body fluids, such as plasma, AF, and CVF, and in discernible subgroups, such as PPROM and PTL patients, we were able to compare diagnostic performances and indicate a possible diagnostic pathway for further investigation and real-world validation.